Blockbuster weight loss drugs could help with alcohol cravings, small new study suggests
Blockbuster weight loss drugs could help with alcohol cravings, small new study suggests
Cikk tartalma röviden
New research suggests that medications for obesity, particularly GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), may also reduce alcohol consumption. The study involved 48 adults over two months, indicating that nearly 40% of participants on semaglutide reported no heavy drinking days, compared to 20% in the placebo group. However, experts caution that more extensive studies are needed to confirm these findings and assess safety for those not seeking weight loss.
New research suggests that medications for obesity, particularly GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), may also reduce alcohol consumption. The study involved 48 adults over two months, indicating that nearly 40% of participants on semaglutide reported no heavy drinking days, compared to 20% in the placebo group. However, experts caution that more extensive studies are needed to confirm these findings and assess safety for those not seeking weight loss.